Skip to content

LSD: all studies

Page 191 of 282: studies 1,901 to 1,910 of 2,815, newest first. Back to the LSD overview

Research

Scanning the new frontier of mental health: psychedelic brain imaging

The Biochemist March 14, 2024 Natalie Ertl, Matthew B. Wall

The use of psychoactive substances for ritual, spiritual and medicinal purposes stretches back into prehistory and has been a common feature of many diverse cultures and societies globally. Psychedelics, with their unique ability to amplify feelings of connectedness and openness, may have also served as tools for promoting tribal cohesion and trust in ancient cultures. Psychedelic is a broad...

DOI: 10.1042/bio_2023_171 (opens in new tab) Full text (opens in new tab) Frontier Brain scanning Mental health Neuroimaging

Psychedelic drugs and the law: What’s next?

Knowable Magazine March 14, 2024 Ben Seal 1 citation

When Oregon's first psilocybin service center opened in June 2023, allowing those over 21 to take mind-altering mushrooms in a state-licensed facility, the psychedelic revival that had been unfolding over the past two decades entered an important new phase. Psilocybin is still illegal on the federal level. But now, as researchers explore the therapeutic potential of psilocybin and other...

Altered states of consciousness

March 13, 2024 Susan Blackmore, Emily T. Troscianko 46 citations

Altered states of consciousness (ASCs) are surprisingly hard to define and to measure. Neither ‘subjective’ methods (like verbal reports) nor ‘objective’ measures (such as how the state is induced, or physiological and behavioural criteria) are entirely satisfactory. Attempts to map ASCs are reviewed, including two- or three-dimensional maps such as Tart&s;s and Laureys’, and Hobson&s;s AIM...

EMBARK Psychedelic Therapy for Depression

March 6, 2024 Bill Brennan, Alex Belser 6 citations

Abstract EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person is a comprehensive guidebook for clinicians that presents a novel therapeutic framework for administering psychedelic medicines. The EMBARK model was developed in response to the growing interest in psychedelic medicines for treating mental health disorders, particularly depression, and the identified gaps...

Insights into Psychoactive Drug Effects: The Role of Drug Discrimination Techniques

Qeios March 5, 2024 Qiu Yan

Psychoactive drugs exert profound effects on the central nervous system, influencing behavior and perception. Understanding these effects is crucial for both scientific research and clinical practice. This article provides an overview of the application of drug discrimination techniques in studying the subjective effects, pharmacological mechanisms, individual differences, and drug...

A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder

Brain Sciences March 3, 2024 Mario Renato Velit-Salazar, Eloise Cherian, Paulo R Shiroma 13 citations

Objective: This study aims to provide an overview of pharmacological trials that examine the neurocognitive effects of psychedelics among healthy individuals and patients with post-traumatic stress disorder (PTSD) or major depressive disorder (MDD). Methods: The Preferred Reporting Items for Systematic Reviews (PRISMA) was used as a guide to structure and report the findings for this review. A...

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

European Neuropsychopharmacology March 1, 2024 Marcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B Silva et al. 25 citations

Psychedelics are being increasingly examined for their therapeutic potential in mood disorders. While the acute effects of ayahuasca, psilocybin, and lysergic acid diethylamide (LSD) last over several hours, inhaled N,N-Dimethyltryptamine (DMT) effects last around 10 min, which might provide a cost- and time-effective alternative to the clinical application of oral psychedelics. We aimed at...

DOI: 10.1016/j.euroneuro.2023.12.006 (opens in new tab) Full text (opens in new tab) Entheogens Clinical trial Dose-response study Mood disorders +6

Does Conformation Affect the Analytical Response? A Structural and Infrared Spectral Evaluation of Phenethylamines (2C-H, 25H-NBOH, and 25I-NBOMe) Using In Silico Methodology

Psychoactives February 25, 2024 L. Mariotto, C. Rodrigues, A. Bruni

The identification of new psychoactive substances (compounds that mimic the effects of outlawed substances) poses a significant challenge due to their rapid emergence and continuous modifications. This phenomenon results in these molecules escaping legal regulation, allowing them to circumvent legislation. The phenethylamine class has garnered attention because its molecules replicate the...

Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.

Molecules February 22, 2024 Hanbo Yao, Xiaodong Wang, Jiaxin Chi et al. 9 citations

Major Depressive Disorder (MDD) is a complex mental disorder that involves alterations in signal transmission across multiple scales and structural abnormalities. The development of effective antidepressants (ADs) has been hindered by the dominance of monoamine hypothesis, resulting in slow progress. Traditional ADs have undesirable traits like delayed onset of action, limited efficacy, and...

Absurdity and Serendipity: Reclined domain for Innovations and Researchers/Discoveries

European journal of applied sciences February 20, 2024 Tahir Nasir

An absurdity is a kind of illogicality and etymologically origin from the Latin word “absurdus-a-um”, means unreasonable or out of place/discordant, etc [1]. Absurdity subsists in an arbitrary campaign besides in the situation arises, being considered as a fiasco to demark an indispensable and meaningful from unnecessary and worthless. Sir Selman Waksman got Albert Lasker award (1948), Nobel...

DOI: 10.14738/aivp.121.14858 (opens in new tab) Serendipity Absurdity Domain mathematical analysis Data science +1